Tobam raised its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 667.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,712 shares of the company’s stock after buying an additional 11,056 shares during the quarter. Tobam’s holdings in Cardinal Health were worth $2,612,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health during the 4th quarter worth approximately $25,000. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust purchased a new position in Cardinal Health in the fourth quarter worth $27,000. Palladiem LLC purchased a new position in Cardinal Health in the fourth quarter worth $28,000. Finally, Elyxium Wealth LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth $34,000. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Stock Performance
NYSE:CAH opened at $222.08 on Friday. The company has a fifty day moving average of $204.34 and a two-hundred day moving average of $209.27. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The stock has a market capitalization of $52.01 billion, a PE ratio of 33.96, a P/E/G ratio of 1.21 and a beta of 0.52.
Cardinal Health Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.
Analyst Ratings Changes
Several brokerages have recently commented on CAH. Robert W. Baird set a $248.00 price objective on Cardinal Health in a report on Friday, May 1st. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Barclays upped their target price on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. William Blair started coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, Wells Fargo & Company reduced their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $246.93.
Check Out Our Latest Analysis on Cardinal Health
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Read More
- Five stocks we like better than Cardinal Health
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
